2023 Vol.41, N°9 - Suppl.135 - Table of contents
LER & CER - Letter to Editor Rheumatology Commentaries and Controversies
LER & CER: letter to Editor Rheumatology
CER14419
2023,41,9,Suppl.135
Pg. 0003
Free to view
Comment on: Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed ‘window of opportunity’ by Giollo et al.
D. Reffat, M. Dziedzic, A. O' Riordan, F. Adeeb
DOI: https://doi.org/10.55563/clinexprheumatol/7ikqxf
D. Reffat, M. Dziedzic, A. O' Riordan, F. Adeeb
DOI: https://doi.org/10.55563/clinexprheumatol/7ikqxf
CER14679
2023,41,9,Suppl.135
Pg. 0004-0005
Free to view
The impact of SARS-CoV-2 infection in children with rheumatic/autoinflammatory diseases on immunosuppressive treatment: a single centre experience
D.N. Maritsi, P. Krepis, G. Vartzelis, A. Syggelou, M. Tsolia
DOI: https://doi.org/10.55563/clinexprheumatol/tvrf33
D.N. Maritsi, P. Krepis, G. Vartzelis, A. Syggelou, M. Tsolia
DOI: https://doi.org/10.55563/clinexprheumatol/tvrf33
CER14579
2023,41,9,Suppl.135
Pg. 0006-0007
Free to view
SARS-CoV-2 infection may not be a prerequisite for developing multisystem inflammatory syndrome in children
J.H. Kwak, J.-W. Choi, S.-Y. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/tfgcms
J.H. Kwak, J.-W. Choi, S.-Y. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/tfgcms
CER14777
2023,41,9,Suppl.135
Pg. 0008
Free to view
Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al.
E. Duran, B.E.S. Yildirim, Ö. Karadağ
DOI: https://doi.org/10.55563/clinexprheumatol/85mraz
E. Duran, B.E.S. Yildirim, Ö. Karadağ
DOI: https://doi.org/10.55563/clinexprheumatol/85mraz
CER15268
2023,41,9,Suppl.135
Pg. 0009-0010
Free to view
Prevalence and characteristics of systemic autoimmune disease-related autoantibodies in convalescent patients after SARS-CoV-2 infection
A. Rosales-Castillo, J.M. Sabio
DOI: https://doi.org/10.55563/clinexprheumatol/csmyb6
A. Rosales-Castillo, J.M. Sabio
DOI: https://doi.org/10.55563/clinexprheumatol/csmyb6
CER15349
2023,41,9,Suppl.135
Pg. 0011-0012
Free to view
Resolution of accelerated nodulosis with upadacitinib in a patient with systemic lupus erythematosus and Jaccoud’s arthropathy
D. Michailidou, T.H. Long, Z.B. Argenyi, E.H. Noss
DOI: https://doi.org/10.55563/clinexprheumatol/hkokxs
D. Michailidou, T.H. Long, Z.B. Argenyi, E.H. Noss
DOI: https://doi.org/10.55563/clinexprheumatol/hkokxs
CER15442
2023,41,9,Suppl.135
Pg. 0013-0016
Free to view
Relapsing polychondritis with ANCA-associated vasculitis: is it a coincidence or an overlapping condition?
G. Wang, N. Zhuo, F. Tian, J. Li, Z. Wen
DOI: https://doi.org/10.55563/clinexprheumatol/m9ardb
G. Wang, N. Zhuo, F. Tian, J. Li, Z. Wen
DOI: https://doi.org/10.55563/clinexprheumatol/m9ardb
CER15624
2023,41,9,Suppl.135
Pg. 0017
Free to view
Eosinophilic fasciitis induced by certolizumab pegol: association or coincidence?
G. Wang, N. Zhuo, Z. Wen
DOI: https://doi.org/10.55563/clinexprheumatol/am8x3p
G. Wang, N. Zhuo, Z. Wen
DOI: https://doi.org/10.55563/clinexprheumatol/am8x3p
CER15810
2023,41,9,Suppl.135
Pg. 0018-0019
Free to view
Paraffin stimulation might not be necessary for the collection of saliva: effect on the rate and cellular distribution in primary Sjögren’s syndrome
K.Y. Abacar, I. Aydin-Tatli, Ş. Çolakoğlu, N. Inanc, G. Mumcu, P. Atagündüz
DOI: https://doi.org/10.55563/clinexprheumatol/vbmcu6
K.Y. Abacar, I. Aydin-Tatli, Ş. Çolakoğlu, N. Inanc, G. Mumcu, P. Atagündüz
DOI: https://doi.org/10.55563/clinexprheumatol/vbmcu6
CER16149
2023,41,9,Suppl.135
Pg. 0020-0021
Free to view
Ten-year-format diary of fever episodes kept over a five-year period by a patient with familial Mediterranean fever
N. Kambe, R. Takimoto-Ito, K. Kabashima
DOI: https://doi.org/10.55563/clinexprheumatol/klx6fi
N. Kambe, R. Takimoto-Ito, K. Kabashima
DOI: https://doi.org/10.55563/clinexprheumatol/klx6fi
CER16396
2023,41,9,Suppl.135
Pg. 0022
Free to view
The management of patients with polymyalgia rheumatica: limitations to get it right
C. Manzo, M. Natale, A. Nune, A. Castagna
DOI: https://doi.org/10.55563/clinexprheumatol/dxmvl1
C. Manzo, M. Natale, A. Nune, A. Castagna
DOI: https://doi.org/10.55563/clinexprheumatol/dxmvl1
CER16524
2023,41,9,Suppl.135
Pg. 0023
Free to view
Reply: Who can get it right for polymyalgia rheumatica?
C.B. Mukhtyar
DOI: https://doi.org/10.55563/clinexprheumatol/1ca61t
C.B. Mukhtyar
DOI: https://doi.org/10.55563/clinexprheumatol/1ca61t
CER16356
2023,41,9,Suppl.135
Pg. 0024
Free to view
Patellar tendon ectopic calcification in a patient with undiagnosed limited cutaneous systemic sclerosis
T. Horino, S. Inotani, Y. Terada
DOI: https://doi.org/10.55563/clinexprheumatol/j2e1n7
T. Horino, S. Inotani, Y. Terada
DOI: https://doi.org/10.55563/clinexprheumatol/j2e1n7
CER17074
2023,41,9,Suppl.135
Pg. 0025-0026
Free to view
Why would immuno- and endocrino-senescence, age-related changes in the gut microbiota, and susceptibility to infection favour polymyalgia rheumatica over seronegative elderly-onset rheumatoid arthritis?
C. Manzo, A. Nune, A. Castagna
DOI: https://doi.org/10.55563/clinexprheumatol/hb7van
C. Manzo, A. Nune, A. Castagna
DOI: https://doi.org/10.55563/clinexprheumatol/hb7van